Abstract 3859
Background
Glioblastoma multiforme (GBM) is the grade IV glioma and the most common adult primary brain tumor. It is notorious for its heterogeneity, invasiveness and resistance to chemo- and radiotherapies. These characteristics make it a highly recurrent malignant disease with poor prognosis. The potential new target for intervention in GBM is its cancer stem cells (GSCs).
Methods
To identify an improved treatment by targeting GSCs, we screened 400 botanical extracts for their effects on cytotoxicity and colony formation ability in GBM cell lines and tumorspheres.
Results
We identified the extracts of Cerbera manghas L. as being effective inhibitors of the growth and migration of GBM cell lines and its tumorspheres. We further demonstrated that neriifolin was one of the active principles. Neriifolin effectively inhibits the growth of CD133+-GBM tumorspheres and their colony formation. The extracts of Cerbera and neriifolin both reduced AKT activation and caused cell cycle G1 arrest while reducing the protein level of the stem cell marker Sox2. Furthermore, higher doses of these treatments induced apoptosis of tumorspheres. In the mouse xenotransplantation model, neriifolin inhibited the growth of CD133+-GBM tumorsphere-derived tumors in vivo.
Conclusions
In summary, neriifolin obtained from extracts of C. manghas may serve as a drug lead compound for GBM therapies.
Clinical trial identification
Legal entity responsible for the study
Department of life Science, National Taiwan Normal University.
Funding
Ministry of Science and Technology, Taiwan, ROC.
Editorial Acknowledgement
Louise T. Chow.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1836 - Clinical and Psychometric validation of the BreSAS Questionnaire for Symptom Assessment among Breast Cancer Survivors.
Presenter: Raffaele Giusti
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
5973 - Association of phase angle and chemotherapy toxicity among Mexican patients with non‐metastatic breast cancer
Presenter: Maria Tereza Nieto Coronel
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
5993 - Hepatitis screening for patients to undergo chemotherapy in Cyprus
Presenter: Panteleimon Kountourakis
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4872 - Hepatitis B virus (HBV), Hepatitis C virus (HCV) and Human Immunodeficiency virus (HIV) screening prior to chemotherapy initiation among patients with solid tumors.
Presenter: Sharon Giordano
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4764 - Rapid identification of bloodstream infection pathogens
Presenter: Natalia Panova
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4753 - Pathogens and characteristics of candidemia in hospitals of Rostov-on-Don. Multicenter study in Russia
Presenter: Olga Kutsevalova
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4388 - Antiviral Prophylaxis Cannot Reduce the Risk of Hepatitis B Reactivation During Chemotherapy for non HCC Solid Tumor Patients with Lower HBV DNA Titer：A Retrospective Cohort Study.
Presenter: qiong qin
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
1371 - Prospective observational study to evaluate the persistence of treatment with denosumab (dmab) in patients (pts) with bone metastases (BM) from solid tumors (ST) in routine clinical practice: final analysis
Presenter: Ferdinand Haslbauer
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
1438 - A multicenter retrospective investigation on the efficacy of perioperative oral management in cancer patients
Presenter: Shin-ichi Yamada
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
1921 - Correlation between fatigue evaluated with a visual analog scale (VAS) and quality of life (QoL) in cancer patients treated with biosimilar epoetin alfa for chemotherapy-induced anemia (CIA): the CIROCO study
Presenter: Jérôme Desrame
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract